The Bridge Project
The Bridge Project is a collaboration between DF/HCC and the Koch Institute, designed to bring bioengineering, advanced cancer science, and clinical oncology together to solve today’s most challenging problems in cancer research and care. Through seed funding for collaborative research teams comprised of both MIT and DF/HCC investigators, the Bridge Project fosters interdisciplinary studies that wed new tools and methods from engineering-based disciplines with advances in cancer biology together with translational expertise of clinical oncologists.
The Bridge Project is designed to reach beyond existing individual networks to establish ties between unmet clinical needs and technological solutions that have not traditionally been connected. Along with the potential for fundamentally new insights into cancer research, the Bridge Project addresses the substantial challenge in “bridging” a significant divide–in scientific language, experimental approaches, and traditional expertise. Through this program, catalytic financial supports will jumpstart pilot cross-disciplinary, cross-institutional, multi-investigator research.
To learn about currently funded Bridge Project research and previously awarded funding, go to the Bridge-Funded Research page.
To encourage the formation of cross-institutional research teams, we regularly hold informational sessions, workshops, and symposia based on complex translational problems in cancer. Visit the Bridge Project Events page to view presentation videos from past events.
Bridge Project Leadership
- Laurie Glimcher, MD, President and CEO, Dana-Farber Cancer Institute
- L. Rafael Reif, PhD, President, MIT
- David Livingston, MD, Deputy Director of the DF/HCC
- Tyler Jacks, PhD, Director, Koch Institute
- David Nathan, MD, President Emeritus, Dana-Farber Cancer Institute
- Susan Hockfield, PhD, President Emerita, President, MIT
If you are interested in supporting the Bridge Project, please contact:
Karen Sveda (DF/HCC)
Assistant Vice President, Principal & Major Gifts
10 Brookline Place
Brookline, MA 02445
Lisa Marks Schwarz (MIT)
Managing Director of Development
Koch Institute for Integrative Cancer Research at MIT, 76-158
Cambridge, MA 02319